Hester Biosciences Sees Profits Soar Amidst Operational Triumphs

Hester Biosciences has witnessed a tremendous surge in its net profit for the first quarter ending June 30, 2025, reporting a figure of Rs 17 crore. This marks a more than twofold increase from the Rs 7 crore recorded in the same period last year.

The company's revenue from operations also saw a rise, reaching Rs 84 crore compared to Rs 82 crore in the previous year, as stated in their recent disclosure. A key factor in this financial uptick is attributed to a turnaround in the operational performance of Hester Africa coupled with improved cost control measures.

In line with its strategic goals, Hester Biosciences continues to bolster its presence across various animal segments, emphasizing operational efficiency, innovation in product development, and market expansion. The firm's shares responded positively, trading 14.39% higher at Rs 2,230.60 on the BSE.

(With inputs from agencies.)